Adenocarcinoma of the prostate is the second most common cancer in men in the United States (following only skin cancer) and accounts for 29 percent of all newly diagnosed male cancers.

It is estimated that in 2007, 218,890 men will be diagnosed with prostate cancer and 27,050 will die from this disease.

Prevention and most important, early detection, are essential to optimizing treatment outcomes.

Estimated New Cases *
			Males	Females
Prostate	218,860	29%			Breast	178,480	26%
Lung & bronchus	114,760	15%			Lung & bronchus	98,620	16%
Colon & rectum	79,130	10%			Colon & rectum	74,630	11%
Urinary bladder	50,040	7%			Uterine corpus	39,080	6%
Non-Hodgkin lymphoma	34,200	4%			Non-Hodgkin lymphoma	28,990	4%
Melanoma of the skin	33,910	4%			Melanoma of the skin	26,000	4%
Kidney & renal pelvis	31,590	4%			Thyroid	25,480	4%
Leukemia	24,800	3%			Ovary	22,430	3%
Oral cavity & pharynx	24,180	3%			Kidney & renal pelvis	19,600	3%
Pancreas	18,830	2%			Leukemia	19,440	3%
All Sites	766,860	100%			All Sites	678,060	100%
Estimated Deaths
			Males	Females
Lung & bronchus	89,510	31%			Lung & bronchus	70,680	26%
Prostate	27,050	9%			Breast	40,460	16%
Colon & rectum	26,000	9%			Colon & rectum	26,180	10%
Pancreas	16,840	6%			Pancreas	16,530	6%
Leukemia	12,320	4%			Ovary	15,280	6%
Liver & intrahepatic bile duct	11,280	4%			Leukemia	9,470	4%
Esophagus	10,900	4%			Non-Hodgkin lymphoma	9,060	3%
Urinary Bladder	9,630	3%			Uterine corpus	7,400	3%
Non-Hodgkin lymphoma	9,600	3%			Brain & other nervous system	5,590	2%
Kidney & renal pelvis	8,080	3%			Liver & intrahepatic bile duct	5,500	2%
All Sites	289,550	100%			All Sites	270,100	100%

Table: Ten Leading Cancer Types for the Estimated New Cancer Cases and Deaths, by Sex, US, 2007.
* Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder. Estimates are rounded to the nearest 10.

–A Jemal et al. Cancer Statistics 2007; CA Cancer J Clin 2007; 57:43-66.